CO-EXISTENT PHEOCHROMOCYTOMA AND THYROID CARCINOMA (SIPPLE'S SYNDROME).
KAYE RH, ZAK FG.
J Mt Sinai Hosp N Y. 1964 Nov-Dec;31:476-86.
Guidelines for diagnosis and therapy of MEN type 1 and type 2.
Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ.
J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71. doi: 10.1210/jcem.86.12.8070.
[Sipple syndrome (review of foreign literature)].
Vetshev PS, Mel'nichenko GA, Kuznetsov NS, Vel'tsevich DG, Smirnov SV.
Khirurgiia (Mosk). 1996;(2):122-7.
Pheochromocytoma in MEN2.
Gild ML, Do K, Tsang VHM, Tacon LJ, Clifton-Bligh RJ, Robinson BG.
Recent Results Cancer Res. 2025;223:211-235. doi: 10.1007/978-3-031-80396-3_8.
La chirurgie d’épargne surrénalienne : du cortex à la médulla: Cortical sparing surgery: from cortex to medulla.
Ferriere A, Kerlan V, Tabarin A.
Ann Endocrinol (Paris). 2017 Oct;78 Suppl 1:S11-S20. doi: 10.1016/S0003-4266(17)30921-6.
Unusual "Hyperparathyroidism".
Outtier AS, Le Bras M, Lerat F, Masson D, Bach-Ngohou K.
Clin Chem. 2017 Feb;63(2):617. doi: 10.1373/clinchem.2016.264499.
RET oncogene.
Mak YF, Ponder BA.
Curr Opin Genet Dev. 1996 Feb;6(1):82-6. doi: 10.1016/s0959-437x(96)90015-5.
Parathyroid hormone-dependent hypercalcemia.
Toke J, Patócs A, Balogh K, Gergics P, Stenczer B, Rácz K, Tóth M.
Wien Klin Wochenschr. 2009;121(7-8):236-45. doi: 10.1007/s00508-009-1149-z.
Sipple's syndrome presenting acutely as severe heart failure.
Gómez Ramos MJ, González Valverde FM, Sánchez Alvarez MC.
Eur J Emerg Med. 2002 Jun;9(2):171-4. doi: 10.1097/00063110-200206000-00014.
[Sipple syndrome].
Vetshev PS, Mel'nichenko GA, Kuzhetsov NS, Ippolitov LI, Solov'eva NA.
Khirurgiia (Mosk). 1996;(5):59-60.
